Market revenue in 2023 | USD 62.7 million |
Market revenue in 2030 | USD 107.5 million |
Growth rate | 8% (CAGR from 2023 to 2030) |
Largest segment | Cardiac |
Fastest growing segment | Dermatology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiac, Dermatology, Nasal |
Key market players worldwide | Medtronic PLC, Becton Dickinson & Co, Edwards Lifesciences Corp, LivaNova PLC, Smiths Group PLC, Boston Scientific Corp |
Cardiac was the largest segment with a revenue share of 46.25% in 2023. Horizon Databook has segmented the U.S. cannula market based on cardiac, dermatology, nasal covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. held the largest share of North America cannula market. This growth can be attributed to presence of large patient pool and increase in the number of surgeries being performed. As per ASPS, minimally invasive cosmetic procedures have increased around 200% since 2000. Among the 17.5 million surgeries performed in 2017, around 15.7 million were minimally invasive cosmetic procedures.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account